Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PCI Biotech Holding Director's Dealing 2016

May 4, 2016

3709_dirs_2016-05-04_7c3f8e9b-911c-432d-b34a-e7ecefc85217.html

Director's Dealing

Open in viewer

Opens in your device viewer

PCI Biotech: Mandatory notification of trade

PCI Biotech: Mandatory notification of trade

Oslo, 4 May 2016 - The primary insider and Board member, Christina Herder, has

purchased 5,000 shares at a price of NOK 7.00 per share. After this, the primary

insider, Christina Herder, holds a total portfolio of 5,000 shares in the

company.

Contact information:

PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo

Per Walday, CEO, [email protected], Mobile: +47 917 93 429

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

[HUG#2010000]